Understanding your resultWhat this marker can mean
Each major atherogenic particle carries one Apo B molecule, so Apo B estimates the number of particles capable of entering artery walls. It can reveal risk that LDL cholesterol alone may miss, particularly with high triglycerides, diabetes, or insulin resistance.
Research contextHow the evidence is used
Large genetic, observational, and clinical-trial analyses support Apo B particle burden as closely related to atherosclerotic risk. Many guidelines use it as a risk-enhancing or secondary treatment marker in selected patients.
A helpful piece—not the whole picture.Laboratory ranges and interpretation vary by age, sex, life stage, symptoms, medications, collection timing, and other results. This educational information is not a diagnosis or individualized medical advice. Practitioner review is not included with lab ordering.